Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon et al. · Annals of Neurology · 1996 · 2.4K citations

Pharmacy, Neurology, Pharmacotherapy +12

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

Neurology · 1993 · 2.1K citations

Pharmacy, Neurology, Pharmacotherapy +14

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

George C. Ebers · The Lancet · 1998 · 2.1K citations

Life Sciences, Immunology, Neurology +8

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations

Pharmacy, Neurology, Pharmacotherapy +15

THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY

Brian G. Weinshenker, B. Bass, George P. Rice et al. · Brain · 1989 · 1.5K citations

Medicine, Neurology, Disability Management +9